Substance abuse

There is substantial clinical need to recognize the individuals who need care for cognitive issues that go beyond normal aging. These problems are noticeable, but clinicians have lacked a reliable diagnosis by which to assess symptoms the most proper treatment or services. Recent studies suggest that identifying mild neurocognitive disorders in the early stages itself may allow interventions to be more effective. Early intervention efforts may enable the use of treatments that are ineffective at more severe levels of impairment and may prevent or slow progression. Researchers will analyze how well the new diagnostic criteria address the depressive symptoms, as well as potential therapies like educational or brain stimulation.

  • lung cancer 
  • emphysema
  • Heart stroke

Related Conference of Substance abuse

April 07-08, 2025

39th International Conference on Psychiatry and Mental Health

Amsterdam, Netherlands
April 10-11, 2025

6th Annual Congress on Psychiatry

Dubai, UAE
April 14-15, 2025

3rd World Congress on Psychiatry

Budapest, Hungary
May 21-22, 2025

7th European Autism Congress

Paris, France
June 16-17, 2025

3rd International Conference onPsychiatry and Psychology

Zurich, Switzerland
June 16-17, 2025

10th International Conference on Addiction Therapy

Zurich, Switzerland
June 16-17, 2025

35th Euro Congress on Psychiatrists and Psychologists

Frankfurt, Germany
June 19-20, 2025

5th Annual Congress on Mental Health

Paris, France
November 10-11, 2025

International Congress on Cognitive Psychotherapy

Vancouver, Canada
November 10-11, 2025

5th Annual Psychiatrists and Psychologists Meet

Vancouver, Canada
November 24-25, 2025

5thAnnual Congress on Mental Health & Psychiatry

Barcelona, Spain
February 16-16, 2026

43rd Global Psychiatry and Mental Health Conference

Paris, France

Substance abuse Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in